Brean Capital Initiates Syneron Medical With Buy
March 03, 2015 at 09:17 AM EST
Analysts at Brean Capital initiated coverage on Syneron Medical Ltd. (NASDAQ: ELOS) with a Buy rating. The target price for Syneron ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |